ENGINEERED CXCL12 ALPHA LOCKED DIMER POLYPEPTIDE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160229900A1
SERIAL NO

15099848

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a novel CXCL12-α2 locked dimer polypeptide, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of cancer, inflammatory disorders, autoimmune disease, and HIV/AIDS.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDICAL COLLEGE WISCONSIN INCNot Provided

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Peterson, Francis C Racine, US 92 3682
Sakmar, Thomas New York, US 4 10
Seibert, Christoph H Frankfurt am Main, DE 4 10
Veldkamp, Christopher T Milwaukee, US 4 10
Volkman, Brian F Muskego, US 9 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation